NEW YORK (GenomeWeb news) – Luminex reported after the close of the market Thursday that its second-quarter 2009 revenues increased 14 percent, and it turned a net loss into a profit when compared with the same period in 2008.

The Austin, Texas-based molecular diagnostics instrumentation and assay maker had revenues of $27.8 million for the three-month period ended June 30, compared to revenues of $24.3 million for the second quarter last year. Analysts, on average, had expected revenues of $29.9 million for Q2 2009.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.